From Innovation to Cash Flows: Value Creation by Structuring High Technology Alliances by Constance Lütolf-Carroll, Antti Pirnes and Withers LLP Copyright © 2009 Constance Lütolf-Carroll with the collaboration of Antti Pirnes
References
3M Corporation. 2007. 3M innovation—How it flourished. In A Century of innovation: The 3M story, 29–48. St. Paul, MN: 3M Company (electronic book). http://multimedia. mmm.com/mws/mediawebserver.dyn?6666660Zjcf6lVs6EVs666IMhCOrrrrQ- (accessed June 5, 2007). Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS). World Trade Organization (WTO). www.wto.org/english/tratop e/trips e/t agm0 e.htm. Allen, Matthew. 2008. Half of start-ups fail after five years, Swissinfo, Zurich, Switzerland. www.swissinfo.org/eng/front.html?siteSect=109&ty=st&sid=8621979 (accessed February 17, 2008). Alsop, Ronald. 2006. MBA Programs blend disciplines to yield big picture. Wall Street Journal. July 11, p. B5. www.yale.edu/opa/download/newsYale/MBA Programs Blend Disciplines 701106.pdf (accessed May 23, 2008). Alzheimer’s Association. 2008. Alzheimer’s disease facts and figures. www.alz.org/ news and events 13106.asp. Anslinger, Patricia L., Steven J. Klepper, and Somu Subramaniam. 1999. Breaking up is good to do. McKinsey Quarterly (1): 16–27 (February). Article 1(1)(i) of European Commission Regulation 772/2004 on the application of Article 81(3) of the Treaty Establishing the European Union to categories of technology transfer agreements (OJ 2004 L123/11). Arzac, Enrique R. 1996. The cost of capital: A synthesis. Working paper. Columbia University Graduate School of Business. AstraZeneca. 2006. AstraZeneca and Pozen Inc. sign deal to develop and commercialise naproxen and esomeprazole fixed dose combinations utilising Pozen’s proprietary technology for the treatment of chronic pain. August 6. www.astrazeneca.com/pressrelease/5265.aspx. AT&T. 2001. An information guide for AT&T share owners. www.att.com/Common/ files/pdf/t awe exchange.pdf (accessed May 16, 2008). Athanassakos, George. 1995. Equity valuation: A guide to discounted cash flow and relative valuation nethods. Monograph. Clarica Financial Services Research Centre. Wilfrid Laurier University, Waterloo, Ontario, Canada. Athanassakos, George. 2005. Note on the discounted cash flow-based valuation methodology as tested by a public market transaction. 9B05N021. Richard Ivey School of Business, University of Western Ontario, Ontario, Canada. Baker, Graham, and Peter Bissell. 2008. Ten lessons from successful inventions. In Invention. London: Design Council. www.designcouncil.org.uk/en/About-Design/BusinessEssentials/Invention/Invention9 (accessed April 30, 2008). Bales, Carter, P.C. Chatterjee, Donald Gogel, and Anupam Puri. 1980. Competitive cost analysis. McKinsey Staff Paper, McKinsey & Company, Inc. www.mckinseyquarterly.com/ strategy.miin00.asp (accessed May 31, 2008). Bamford, James, David Ernst, and David G. Fubini. 2004. Launching a world-class joint venture, Harvard Business Review 82, no. 2 (February): 90–100.
589
590
REFERENCES
Barney, Jay. 1991. Firm resources and sustained competitive advantage. Journal of Management 17: 99–120. Bassar, Shanny. 2008. Analysts raise infrastructure spending forecasts. Dow Jones Financial On-line News, June 23. www.efinancialnews.com/assetmanagement/index/ content/2451016799 (accessed June 23, 2008). Bazerman, Max H., and Margaret A. Neale. Negotiating rationally. 1993. New York: Free Press. Beamish, Paul W. 2003. The design and management of international joint ventures. In International management: Text and cases, 5th ed., 120–139. New York: McGraw-Hill. Beaver, William H. 1989. Financial reporting: An accounting revolution. Englewood Cliffs, NJ: Prentice-Hall. Bleeke, Joel and David Ernst. 1991. The way to win in cross-border alliances. Harvard Business Review 69, no. 6 (November-December): 127–135. Block, Stanley B. 2007. The liquidity discount in valuing privately owned companies. Journal of Applied Finance. vol 17, no. 2 (Fall–Winter): 33–40. Bodily, Samuel E. and Robert F. Bruner, and Pierre Jacquet. 1999. Genzyme/Geltex pharmaceuticals joint venture. Case. UVA-F-1254, version 2.2. Darden Business Publishing, University of Virginia. (April 20). Bolles, Richard N. 2004. What color is your parachute: A practical manual for job-hunters and career-changers. Berkeley, CA: Ten Speed Press. Bonabeau, Eric, Neil Bodick, and Robert W. Armstrong. 2008. A more rational approach to new-product development. Harvard Business Review 86, no. 3 (March): 96–99. Borgida, E., and R.E. Nisbett. 1977. The differential impact of abstract versus concrete information on decisions. Journal of Applied Social Psychology 7, 258–271. Bruner, Robert F. 2004. Applied Mergers & Acquisitions. Hoboken, NJ: John Wiley & Sons. Bruner, Robert F. 2004. Due diligence. In Applied Mergers & Acquisitions, 183–204. Hoboken, NJ: John Wiley & Sons. Bruner, Robert F. 2004. An introduction to deal design in M&A. In Applied Mergers & Acquisitions, 531–546. Hoboken, NJ: John Wiley & Sons. Bruner, Robert F. 2005. Deals from hell—M & A lessons that rise above the ashes. Hoboken: John Wiley & Sons. Bruner, Robert F., and Sean Carr. 2005. Arcadian Microarray Technologies, Inc. Case. UVAF-1496 (December 9). Bruner, Robert F., Kenneth M. Eades, Robert S. Harris, and Robert C. Higgins. 1998. Best practices in estimating the cost of capital: Survey and synthesis. Journal of Financial Practice and Education (Spring-Summer): 13–28. Burgleman, Robert A., Clayton M. Christensen, and Steven C. Wheelwright. 2003. Strategic Management of Technology and Innovation, 4th ed. New York: McGraw-Hill/Irwin. Burrill, G. Steven. 2008. Biotech 2008: A global transformation. A presentation for the conference titled Wisconsin Life Sciences Transformation: World Perspectives & Wisconsin’s Advantage. February 21. Madison, WI. www.burrillandco.com. Business Insights. 2007. Optimizing partnerships with contract organizations: Effective management, key issues, and the development of virtual pharmacos 167 (November). www.researchandmarkets.com/reports/c78869. Cary, Lucius. 1998. Lucius Cary’s guide to raising capital for the smaller business. Oxford, UK: Seed Capital Ltd. and Venture Capital Report Ltd. Celani, Claudio. 2004. The story behind Parmalat’s bankruptcy. Executive Intelligence Review, January 16. www.larouchepub.com/other/2004/3102parmalat invest. html (accessed September 4, 2008). Chaplinsky, Susan. 2003. Note on PIPES: Private equity investment in distressed firms. UVA F-1412. University of Virginia, Darden School Foundation.
References
591
Chaplinski, Susan, and Richard Crawford. 2003. MicroStrategy Incorporated: PIPE. Case. UVA F-1368. University of Virginia, Darden School Foundation. Chesbrough, Henry. 2003. Open innovation—The new imperative for creating and profiting from technology. Boston: Harvard Business School Press. Chesbrough, Henry. 2006. Open business models: How to thrive in the new innovation landscape. Boston: Harvard Business School. Chesbrough, Henry, Wim VanHaverbeke, and Joel West, eds. 2006. Open innovation: Researching a new paradigm. Oxford: Oxford University Press. Chiron Corporation v. Organon Teknika Ltd. 10 FSR 325, 1995, p. 6, column 2, paragraph 2, line 7–9. Christensen, Clayton M. 1997. The innovator’s dilemma: When new technologies cause great firms to fail. Boston: Harvard Business Press. Christensen, Clayton M., and Richard S. Rosenbloom. 1995. Explaining the attacker’s advantage: Technological paradigms, organizational dynamics, and the value network. Research Policy 24 (2): 233–57. Clariant corporate web site: www.clariant.com/corporate/internet.nsf/vwWeb PagesByID/B4E9CB47E92E455BC125712C0052516C (accessed May 14, 2008). Coco v. AN Clark (Engineers) Limited. 1969. Reports of Patent Cases 41, at 47 (England). Continental AG press release. 2007. Energy storage systems for the GM Chevrolet “E-Flex” electric vehicle propulsion system. June 21. www.conti-online.com/generator/www/com/ en/continental/portal/themes/press services/press releases/products/automotive systems/ gt pr 2007 06 21 gm en.html (accessed March 20, 2008). Contract Pharma. Contract services, including contract manufacturing, for the pharmaceutical industry. www.contractpharma.com (accessed December 7, 2008). Copeland, Tom, Tim Koller, Jack Murrin, and McKinsey & Company. 2000. Valuation: Measuring and managing the value of companies, 3rd ed. Indianapolis, IN: John Wiley & Sons. Copyright Designs and Patents Act 1988, United Kingdom, Section 213. Copyright Designs and Patents Act 1988, United Kingdom, Section 91(1). Cordis Europa. See under the EU Cooperation programme, the European technology platforms (ETPs), and Research for the benefit of SME programmes. http://cordis.europa.eu/fp7/ sme en.html (accessed December 7, 2008). Cottle, Sidney, Roger F. Murray, Frank E. Block, with the collaboration of Martin L. Leibowitz. 1988. Graham and Dodd’s Security Analysis, 5th ed. New York: McGraw-Hill. Cowen & Co. Investment bank for high technology and life sciences. www.cowen.com (accessed December 7, 2008). Decision of the Fourth Board of Appeal of the Office for Harmonization in the Internal Market of the European Union of 27 September 2007–R 708/2006–4–Tarzan Yell (Sound Mark). Deeds, D.L., D. DeCarolis, and J. Coombs. 1999. Dynamic capabilities and new product development in high technology ventures: An empirical analysis of new biotechnology firms. Journal of Business Venturing 15: 211–229. DeGarmo, E. Paul, John R. Canada, and William G. Sullivan. 1979. Engineering economy. New York: Macmillan. DiMasi, J.A., and H.G. Grabowski. 2007. The cost of biopharmaceutical R&D: Is biotech different? Managerial and Decision Economics 28: 469–479. DiMasi, J.A., R.W. Hansen, and H.G. Grabowski. 2003. The price of innovation: New estimates of drug development costs. Journal of Health Economics 22, 151–185. Dimson, Elroy, Paul R. Marsh, and Mike Staunton. 2005. Global investment returns yearbook for 2005. London: ABN-AMRO and London Business School, 180. Dollinger, Marc J. 2008. Networking and alliances. In Entrepreneurship: Strategies and resources, 4th ed., 357–364. Lombard, IL: Marsh Publications.
592
REFERENCES
Dossani, Rafiq, and Martin Kenney. 2003. Went for cost, Stayed for quality?: Moving the back office to India. Working Paper, Walter H. Shorenstein Asia-Pacific Research Center (APARC) Stanford University, November. http://aparc.stanford.edu/publications/ went for cost stayed for quality moving the back office to india. Dow Jones Private Equity Analyst. 2008. U.S. private equity firms raise $132.7 billion in 1st half of 2008, 3% behind last year’s record pace. (July 8). www.reuters.com/article/ pressRelease/idUS110280+08-Jul-2008+PRN20080708 (accessed December 28, 2008). Due diligence horror stories. www.astute diligence.com/Diligence Horror.htm#ip (accessed April 6, 2008). The Economist 2008. Where have all your savings gone? vol 389, no. 8609 (December 6), p. 11. Edwards, M., F. Murray, and R. Yu. 2006. Gold in the ivory tower: Equity rewards of outlicensing. Nature Biotechnology 24 (5): 509–515. Eisenhardt, Kathleen M., and Jeffrey A. Martin. 2000. Dynamic capabilities: What are they? Strategic Management Journal 21: 1105–21. Eldridge, Jeanette. 2006. Data visualisation tools—A perspective from the pharmaceutical industry. World Patent Inform 28 (1) (March): 43–49. Ellis, Charles D. 2006. Joe Wilson and the creation of Xerox. Hoboken, NJ: John Wiley & Sons. Energy Biosciences Institute. EBI Fact Sheet. http://67.199.70.53/index.php?option=com content&task=view&id=51&Itemid=90. European Medicines Agency. The European Union and the FDA working together to create common application for orphan designation for medicines. Doc. Ref. EMEA/557391/ 2007). Orphan drug status definition. www.emea.europa.eu/pdfs/ general/direct/pr/ 55739107en.pdf (accessed July 6, 2008). European Patent Convention, Article 52(1), October 5, 1973. European Patent Convention, Article 52(2), October 5, 1973. European Patent Convention, Article 52(2)(c), October 5, 1973. European Patent Office. 2007. The “big five offices” move towards closer cooperation. www.epo.org/topics/news/2007/070522.html (accessed April 30, 2008). European Patent Office. epoline database. Online services—the way to do IP. www.epoline. org/portal/public (accessed on May 8, 2008). Farrell, Diana, and the McKinsey Global Institute. 2006. Smarter offshoring. Harvard Business Review 84, no. 6 (June): 84–92. Financial Accounting Standards Board. 2002. Statement of Financial Accounting Concepts No. 7: Using cash flow information and present value in accounting measurements. (February): 1–53. Downloadable from: www.fasb.org/pdf/con7.pdf (accessed on February 14, 2009). Fisher, Irving. 1896. Appreciation and interest. Publications of the American Economic Association 11, 1–100. Foster, George, and Andrea Higuera. 2002. GenPharm International. Case. IB38. Stanford Graduate School of Business. (September 5). Frew, Sarah E., Stephen M. Sammut, Alysha F. Shore, Joshua K. Ramjist, Sara Al-Bader, Rahim Rezaie, Abdallah S. Daar, and Peter A. Singer. 2008. Chinese health biotech and the billion-patient market. Nature Biotechnology 26, 37–53. DOI: 10.1038/nbt0108–37. www.nature.com/nbt/journal/v26/n1/abs/nbt0108–37.html. Frost & Sullivan. 2008. Widening innovation—Productivity gap in the pharmaceutical industry—New challenges and future directions. www.frost.com/prod/servlet/marketinsight-top.pag?Src=RSS&docid=128394740 (accessed June 12, 2008). Frueh, Feliz W. 2005. Personalised medicine, what is it? How will it affect healthcare? 11th Annual FDA Science Forum. April 26. www.fda.gov/cder/genomics/scienceForum 2005.pdf.
References
593
Garcia, S. 2006. Trends in life science partnering, collaborations and strategic alliances. Fenwick and West LLP publication. www.fenwick.com. Garnier, Jean-Pierre. 2008. Rebuilding the R+D engine in Big Pharma. Harvard Business Review 86, no. 5 (May): 69–76. Gelb, Michael J. 1998. How to think like Leonardo da Vinci: Seven steps to genius every day. New York: Bantam. Genentech, Inc. Herceptin (Trastuzumab) HER2—metastastic breast cancer treatment. www.herceptin.com/hcp/index.jsp (accessed December 7, 2008). Genzyme Corporation. 2007. Annual report, p. 10. www.genzyme.com. Given, Ruth, Glenn H. Snyder, and Dong Wei. 2005. Critical factors for alliance formation: Insights from the Deloitte research biotech alliance survey. A Deloitte Research Life Sciences Study. June: 1–24. Deloitte Research, part of Deloitte Services LLP. www.deloitte.com/dtt/cda/doc/content/DTT DR BIOTECH June05Final% 282%29.pdf (accessed July 6, 2008). Gloeckler, Geoff. 2005. Stanford’s new-look MBA: A top B-school moves to tailor its program to fit the needs of individual students and challenge them at their separate skill levels. BusinessWeek.com, June 5. www.businessweek.com/bschools/content/ jun2006/bs2006065 4760 bs001.htm (accessed May 23, 2008). Gluck, Fred. 1980. Strategic choice and resource allocation. McKinsey Quarterly 1 (Winter): 22–33. Goldman Sachs. Private equity—Mezzanine funds. www2.goldmansachs.com/services/ investing/private-equity/mezzanine/index.html (accessed September 8, 2008). Goleman, Daniel. 1995. Emotional intelligence. New York: Bantam. Goleman, Daniel, Richard Boyatzis, and Annie McKee. 2002. Primal leadership: Realizing the power of emotional intelligence, Boston: Harvard Business School Press, especially Appendix B, Emotional Intelligence: Leadership Competencies. Goodall, Simon, Bart Janssens, Kim Wagner, John Wong, Wendy Woods, and Michael Yeh. 2006. The promise of the East: India and China as R&D options. Nature Biotechnology, July 25. DOI: 10.1038/bioent910. www.nature.com/bioent/2006/060701/full/ bioent910.html. Google Patents. 2008. www.google.com/patents (accessed May 8, 2008). Google Scholar. 2008. http://scholar.google.com (accessed May 8, 2008). Gowers, Andrew. 2006. Gowers Review of Intellectual Property. (December). This document is found on the U.K. Treasury’s web site, go to www.hm-treasury.gov.uk/ d/pbr06 gowers report 755.pdf (accessed December 19, 2008). Graham, Benjamin, and David L. Dodd. 1934. Security analysis. (Reprint of the classic 1934 ed.) New York: McGraw-Hill. Grant, Robert M. 2008a. Cases to accompany contemporary strategy analysis, 6th ed. Malden, MA: Blackwell Publishers. Grant, Robert M. 2008b. Contemporary strategy analysis, 6th ed. Malden, MA: Blackwell Publishers. Grove, Andrew S. 1996. Only the paranoid survive. New York: Doubleday. Hamel, Gary, and C.K. Prahalad. 1994. Competing for the future. Boston: Harvard Business Press. Hamscher, Walter. 1997. Technology due diligence. PriceWaterhouse Review (December). www.hamscher.com/Docs/Tdd US.pdf (accessed April 30, 2008). Hatch, James E. 2008. Note on valuing a biotech company. 9B08N005. Richard Ivey School of Business, The University of Western Ontario. (March 11). Hatch, James E., and Paul Asmundson. 2001. Chromos Molecular Systems, Inc. Case. 9B01N001. Richard Ivey School of Business, The University of Western Ontario. (June 20).
594
REFERENCES
Hatch, James E., and Dennis Dussin. 2001 and 2008. Note on private company valuation. 9B01N009. Richard Ivey School of Business, The University of Western Ontario. Originally issued July 11, 2001, revised and updated on June 30, 2008. Hatch, James E., and Aseema Singh. 2002. Proto5. Case. 9B02N019. Richard Ivey School of Business, The University of Western Ontario. (Nov. 29). Hayes, Robert H., Gary P. Pisano, David M. Upton, and Steven C. Wheelwright. 2004. Operations, strategy, and technology: Pursuing the competitive edge. Indianapolis, IN: John Wiley & Sons. Higgins, Robert C. 2007. Analysis for financial management, 8th ed. New York: McGrawHill/Irwin. Hill, Charles W.L., and Gareth R. Jones. 1988. Strategic management: An integrated approach. Boston: Houghton Mifflin. Hogoboom, John D. 2004. Private investment in public equity: An overview. New Jersey Law Journal, August 16. www.sec.gov/info/smallbus/gbfor25 2006/hogoboom invest.pdf (accessed September 8, 2008). Howe, Jeff. 2006. The rise of crowdsourcing. Wired Magazine. www.wired.com/wired/ archive/14.06/crowds.html. Hundertmark, Thomas, Andr´e Olinto do Valle, and Jeff A. Shulman. 2008. Managing capital projects for competitive advantage. McKinsey Quarterly online ed. (June): 1–10. www. mckinseyquarterly.com/Managing capital projects for competitive advantage 2163. Investopedia. 2008. Leveraged buyout (LBO). www.investopedia.com/terms/l/leveragedbuyout .asp (accessed April 30, 2008). Irvine & Ors v TalkSport Limited. 2003. EWCA Civ 423, (England and Wales Court of Appeal): April 1, 2003. Ius Mentis. 2007. Internet law, IP law and technology explained, for lawyers and engineers. www.iusmentis.com (accessed April 30, 2008). Jacobs, Nancy L. 1995. Evaluating investment performance. In Portable MBA in investment, ed. Peter L. Bernstein. New York: John Wiley & Sons, p. 308. Johnson, Gerry, and Kevan Scholes. 1999. Networks. In Exploring corporate strategy, text and cases, 6th ed., pp. 452–455. Harlow, Essex, UK: Pearson Education, Financial Times Prentice-Hall imprint. Kaplan, Robert S., and David P. Norton. 1996. The balanced scorecard: Translating strategy into action. Boston: Harvard Business Press. Kay, John. 1994. Foundations of corporate success: How business strategies add value. New York: Oxford University Press. Kellogg, David, and John M. Charnes. 2000. Real-options valuation for a biotechnology company. Financial Analysts Journal (May-June): 76–87. Koeplin, John, Atulya Sarin, and Alan C. Shapiro. 2000. The private company discount. Journal of Applied Corporate Finance. Vol. 12, No. 4, (Winter): 94–101. http://ssrn.com/abstract=251776 (accessed February 14, 2009). Khilji, S.E., T. Mroczkowski, and B. Bernstein, 2006. From invention to innovation: Toward developing an integrated innovation model for biotech firms. Journal of Product Innovation Management 23 (6): 528–540. The King v. Arkwright, 1785, 1. Law Reports of Patent Cases: 1602–1842 by William Carpmael, p. 57, lines 22–30. London: Printed and Published by A. Macintosh, 1851. Lachman, Ranan. 2004. The biotech licensing challenge. Drug Discovery and Development (October): 11–15. Landler, Mark, and Daniel J. Wakin. 2004. The rise and fall of Parma’s first family. New York Times, January 11. http://query.nytimes.com/gst/fullpage.html? res=9A03E1DA 1630F932A25752C0A9629C8B63 (accessed August 25, 2008). Lax, David A., and James K. Sebenius. 1986. The manager as negotiator: Bargaining for cooperation and competitive gain. New York: Free Press.
References
595
Leach, Chris J., and Ronald W. Melicher. 2003. Entrepreneurial finance. Mason, OH: SouthWestern, a division of Thomson Learning. Leavitt, Harold J. 1986. Corporate pathfinders: How visionary managers use imaginative strategies to shape the future of their companies. New York: Dow Jones Irwin. Leavitt, Harold J. 1988. On teaching what we haven’t taught. Research Paper Series No. 1005, Stanford University Graduate School of Business (August). https://gsbapps. stanford.edu/researchpapers/library/RP1005.pdf (accessed March 9, 2008). Leonard-Barton, Dorothy. 1992. Core capabilities and core rigidities: A paradox in managing new product development. Strategic Management Journal 13: 111–125, in the Special Issue: Strategy Process: Managing Corporate Self-Renewal (Summer). Lieberman, Marvin B., and David B. Montgomery. 1988. First-mover advantages. Strategic Management Journal 9: 41–58. Lint, Onno, and Enrico Pennings. 2001. An option approach to the new product development process: A case study at Philips Electronics. R & D Management 31 (2): 163–172. DOI 10.1111/1467–9310.00206. MacCormack, Alan, Theodore Forbath, Peter Brooks, and Patrick Kalaher 2007a. From outsourcing to global collaboration: New ways to build competitiveness. Working paper 07–080, Harvard Business School. MacCormack, Alan, Theodore Forbath, Peter Brooks, and Patrick Kalaher. 2007b. Innovation through global collaboration: A new source of competitive advantage. Working paper 07–079, Harvard Business School. Malnight, Thomas, and Tracey Keys. 2007. Surf the storm: Global trends survey results. Perspectives for Managers 152 (November). www.imd.ch/research/publications/ pfm.cfm (accessed May 31, 2008). March, James G. 1994. A primer on decision making: How decisions happen. New York: Free Press. March, James G. 1999. The pursuit of organizational intelligence. Malden, MA: Blackwell Publishers. March, James G., and Daniel A. Levinthal. 1993. The myopia of learning. Strategic Management Journal 14: 95–112. McDougall, Paul, and J. Nicolas Hoover. 2008. Nokia’s Symbian deal rewrites the smartphone rules. InformationWeek, June 28. www.informationweek.com/story/showArticle. jhtml?articleID=208801196 (accessed June 28, 2008). McKinsey & Company, 2008a. “Classic McKinsey frameworks that continue to inform management thinking,” dated July 2008, downloadable at www.mckinseyquarterly. com/Strategy/Strategic Thinking/Enduring ideas 2170 (accessed December 12, 2008). McKinsey & Company, 2008b. “Enduring Ideas: The 7-S Framework”, March 2008, downloadable at www.mckinseyquarterly.com/Enduring ideas The 7-S Framework 2123 (accessed December 12, 2008). Meller, Steve. 2008. Open innovation: Food and pharma opportunities. Paper presented at the European Technology Platform (EPT), Food for Life, Food-Pharma Industry workshop, January 31–February 1, Cork, Ireland. See also www.etp.ciaa.be. Nature Biotechnology’s Portal. Bioentrepreneur—from bench to boardroom. www.nature. com/bioent/index.html (accessed June 30, 2008). O’Brien, Kevin J. 2008. Nokia in deal to make mobile software free. International Herald Tribune, June 25, Technology & Media Section, European ed., 15. O’Reilly, Charles, and Michael L. Tushman. 2007. Ambidexterity as a dynamic capability: Resolving the innovator’s dilemma. Research Paper Series No. 1963, Stanford University Graduate School of Business (March). http://ssrn.com/abstract=978493 (accessed May 15, 2008). Orphan drug status definition. www.emea.europa.eu/pdfs/general/direct/pr/ 55739107en. pdf.
596
REFERENCES
Oster, Sharon M. 1999. Modern competitive analysis, 3rd ed. New York: Oxford University Press. Oxford Technology. 2007. Oxford Technology 3–VCT Newsletter. About companies: Glide Pharma. (September 11): 1-2. www.oxfordtechnology.com/downloads/newletters/ OT3 newsletter.pdf. (accessed December 30, 2008). P&G: Connect + Develop, Procter & Gamble’s Innovation Portal. https://secure3. verticali. net/pg-connection-portal/ctx/noauth/PortalHome.do. Papadopoulos, Stelios. 2000. Business models in biotech. Nature Biotechnology, 18 Industry Trends: A snapshot of biotechnology. Supplement: IT3-IT4. www.nature.com/nbt/ journal/v18/n10s/abs/nbt1000 IT3.html. Pascale, Richard T. 1984. Perspectives on strategy: The real story behind Honda’s success. California Management Review 26 (3) (Spring): 47–72. Penrose, Edith. 1959. The theory of the growth of the firm. New York: John Wiley & Sons. Pereiro, Luis E. 2002. Valuation of companies in emerging markets: A practical approach. New York: John Wiley & Sons. Pereiro, Luis E., and M. Galli. 2000. La determinacion ´ del costo del capital en la valuacion ´ de empresas de capital cerrado: una gu´ıa practica. (The determination of the cost of capital ´ in the valuation of corporations: A practical guide) Buenos Aires: Instituto Argentino de Ejecutivos de Finanzas y Universidad Torcuato Di Tella. Porter, Michael E. 1979. How competitive forces shape strategy. Harvard Business Review 57, no. 2 (March-April): 137–145. Porter, Michael E. 1980. Competitive strategy: Techniques for analyzing industries and competitors. New York: The Free Press. Porter, Michael E. 1985. Competitive advantage: Creating and sustaining superior performance. New York: The Free Press. Porter, Michael E. 1996. What is strategy? Harvard Business Review 74, no. 6 (NovemberDecember): 61–68. Porter, Michael E. 1990a. The competitive advantage of nations. Harvard Business Review, 68, no. 2 (March-April): 73–93. Porter, Michael E. 1990b. The competitive advantage of nations. New York: The Free Press. Porter, Michael E., and Rebecca E. Wayland. 1995. Global competition and the localization of competitive advantage. Proceedings of the Integral Strategy Collegium, Graduate School of Business, Indiana University. Advances in Strategic Management, vol 11, part A. Greenwich, CT: JAI Press. Prahalad, C.K. and Gary Hamel. 1990. The core competence of the corporation. Harvard Business Review 68, no. 3 (May–June): 79–91. Prahalad, C.K., and M.S. Krishnan. 2008. The new age of innovation. New York: Doubleday. Pratt, Shannon P. 2001. Business valuation discounts and premiums. New York: John Wiley and Sons. Private Equity Council. 2008. Private equity funds tax treatment of carried interests. www.privateequitycouncil.org/public-policy/legislative/private-equity-funds-taxtreatment-of-carried-interests (accessed August 8, 2008). Ray, Michael L., and Rochelle Myers. 1986. Creativity in business. New York: Doubleday. Reilly, Frank K., and Rashid A. Akhtar. 1995. The Benchmark error problem with global capital markets. Journal of Portfolio Management 22, no. 1 (Fall): 33–52. Reilly, Frank K., and Keith C. Brown. 2003. Investment analysis and portfolio management. 7th ed. Mason, Ohio: South-Western, Thomson Learning. Restatement of Torts. 1939. American Law Institute, paragraph 757, comment b. Rigby, Darrell. 2008. Bain & Company’s management tools: Offshoring. www.bain.com/ management tools/tools offshoring.asp?groupCode=2. Roberts, John. 2004. The modern firm: organizational design for performance and growth. New York: Oxford University Press.
References
597
Roche.com. Background information: The AmpliChip CYP450 DNA chip. www.roche. com/med backgr-ampli.htm (accessed July 6, 2008). Rottman, Joseph W., and Mary C. Lacity. 2006. Proven practices for effectively offshoring IT Work, MIT Sloan Management Review 47 (Spring): 56–63. Saloner, Garth, Andrea Shepard, and Joel M. Podolny. 2004. Strategic management. Hoboken, NJ: John Wiley & Sons. Saltman Engineering Co. Limited v. Campbell Engineering Co. Limited. 1948. 65 Reports of Patent Cases 203, at 215 (England). Sampath, Prabakar. 2008. Widening innovation—Productivity gap in the pharmaceutical industry—New challenges and future directions. Frost & Sullivan. April 22. www.frost.com/prod/servlet/market-insight-top.pag?Src= RSS&docid=12839470. Sebenius, James. 1996. Introduction to negotiation analysis: Structure, people, and context. Note. Harvard Business School no. 9–896–034. Shane, Scott Andrew. 2004. Academic entrepreneurship: University spinoffs and wealth creation. Northhampton, Ma: Edward Elgar Publishing. Sharpe, William F. 1964. Capital asset prices: A theory of market equilibrium under conditions of risk. Journal of Finance 19 (3): 425–442. Sharpe, William F., Gordon J. Alexander, and Jeffery V. Bailey. 1995. Investments. Upper Saddle River, NJ: Prentice-Hall. Shockley, Richard L. Jr., Staci Curtis, Jonathan Jafari, and Kristopher Tibbs. 2002. The option value of an early stage biotechnology investment. Journal of Applied Corporate Finance 15 (2) (Fall). Smith, Gordon V., and Russell L. Parr. 2005. Intellectual property: Valuation, exploitation, and infringement damages. Hoboken, NJ: John Wiley & Sons. Smith, Gordon V., and Russell L. Parr. 2007. Risk-adjusted cash flows, pp. 23–39. In Cumulative supplement to Intellectual property: Valuation, exploitation, and infringement damages. Hoboken, NJ: John Wiley & Sons. Springboard Business Plan Guide. www.connect.org/resources/docs/Springboard Business Plan Guide.pdf (accessed May 15, 2008). Statement of Financial Accounting Concepts No. 7. Using cash flow information and present value in accounting measurements. 2000. Norwalk, CT: Financial Accounting Standards Board of the Financial Accounting Foundation. Stephenson, Elizabeth, and Adarsh Pandit. 2008. How companies act on global trends: A McKinsey global survey, conducted in March 2008. McKinsey Quarterly (April): 1–9. www.mckinseyquarterly.com/How companies act on global trends A Mc-Kinsey Global Survey 2130 abstract (accessed July 6, 2008). STNAnaVist. STN Interfaces, FIZ Karlsruhe. www.stn-international.com/stninterfaces/ stnanavist/stn anavist.html(accessed May 8, 2008). Stobbs, G.A. 2000. Software patents. New York: Aspen Publishers. Strebel, Paul, and Tracey Keys, eds. 2005. Mastering executive education: How to combine content with context and emotion—The IMD guide. Edinburgh Gate, Harlow, UK: Pearson Education Ltd. Sweet & Maxwell. 1998. A practical guide to patent law. 3rd ed. London: Sweet & Maxwell. Tadelis, Steven. 2007. The innovative organization: Creating value through outsourcing. California Management Review, 50, no. 1 (Fall): 260–277. Teece, David J., Gary Pisano, and Amy Shuen. 1997. Dynamic capabilities and strategic management. Strategic Management Journal 18: 509–533. Teisberg, Elizabeth Olmsted. 1991a. Strategic response to uncertainty. Note. Harvard Business School no. 9–391–192, published April 11, 1-12. DOI: 10.1225/391192. Teisberg, Elizabeth Olmsted. 1991b. Why do good managers choose poor strategies? Note. Harvard Business School no. 9–391–172, published March 5, 1–9. DOI: 10.1225/ 391172.
598
REFERENCES
Trademark Act of 1946. 60 Stat. 427, as amended, codified in United States Code, Title 15, paragraph 1127. Trigeorgis, Leon. 1996, reprinted 1997. Real options: Managerial flexibility and strategy in resource allocation. Cambridge, MA: MIT Press. Trippe, Anthony J. 2003. Patinformatics: Tasks to tools. World Patent Information 25 (3) (September): 211–221. DOI: 10.1016/S0172–2190(03)0079–6 (accessed July 6, 2008). Tushman, Michael L., and Charles A. O’Reilly III. 1997. Winning through innovation: A practical guide to leading organizational change and renewal. Boston: Harvard Business Press. Tversky, Amos, and Daniel Kahneman. 1973. Availability: A heuristic for judging frequency and probability. Cognitive Psychology 5: 207–232. Tversky, Amos, and Daniel Kahneman. 1974. Judgement under uncertainty: Heuristics and biases. Science 185, 1124–1131. UK Intellectual Property Office. 2006. History of patents. www.ipo.gov.uk/about/aboutourorg/about-history/about-history-patent.htm(accessed April 30, 2008). United States Code. 2008. Title 17. Paragraph 302. Duration of copyright: Works created on or after January 1, 1978. United States Code. 2008. Title 35. Chapter 10, paragraph 101. Inventions patentable. United States District Court of the Southern District of New York. Final Approval Order and Settlement signed by Judge Miriam Cedarbaum. October 20, 2006, AT&T Corporation: AT&T wireless group tracking stock. http://securities.stanford.edu/ 1016/AWE00/index.html Stanford Law School Securities Class Action Clearinghouse in association with Cornerstone Research (accessed February 10, 2008). United States Patent and Trademark Office. Patent Electronic Business Center. 2008. www.uspto.gov/ebc/index.html(accessed May 8, 2008). United States Patent and Trademark Office. Patent Full-Text and Full-Page Image Databases. 2008. www.uspto.gov/patft/index.html (accessed May 8, 2008). U.S. Securities and Exchange Commission. SEC Filings and Forms (EDGAR). 2008. www.sec. gov/edgar.shtml (accessed May 8, 2008). Van Arnum. 2007. CMOs expand biologic manufacturing. http://pharmtech.findpharma. com/pharmtech/article. Van Horne, James C. 1994. Financial markets rates and flows, 4th ed. Upper Saddle River, NJ: Prentice-Hall, p. 77. von Arx, Mirjam, 2005. Building the Gherkin: A documentary film. www.buildingthegherkin. com (accessed April 16, 2008). Watkins, Michael D. 2002. Negotiating strategic alliances. Note. Harvard Business School no. 9–902–166, June 20, 1–8. DOI: 10.1225/902166. Watkins, Michael D. 2003. Analyzing complex negotiations. Note. Harvard Business School no. 9–903–088, December 1, 1–22. DOI: 10.1225/903088. Webster’s new world dictionary of the American language, 2nd college ed. 1970. New York: World Publishing Company. Weeds, Helen. 2002. Real options and game theory: When should real options valuation be applied?” Working paper, Cambridge University. WHO aging data. www.who.int/features/factfiles/ageing/en/index.html (accessed December 7, 2008). WHO obesity data. www.who.int/mediacentre/factsheets/fs311/en/index.html (accessed December 7, 2008) Williams, John Burr. 1938. The theory of investment value. Cambridge, MA: Harvard University Press. Reprinted 1964 by North-Holland Publishing Company, Amsterdam. World Intellectual Property Organization. See under Paris Convention for the Protection of Industrial Property. www.wipo.int/treaties/en/ip/paris/trtdocs wo020.html (accessed April 30, 2008).
